Japan Said Probing Alleged GSK-Written Article Used In Subsidy Approval
This article was originally published in PharmAsia News
Executive Summary
Japan's health ministry is investigating allegations GlaxoSmithKline's Cervarix vaccine against cervical cancer won approved for health coverage in part because of a journal article backed by the U.K. drug maker, sources said.